Skip to main content
logo
Rhythm Biosciences Limited (ASX:RHY)
Australia flag Australia · Delayed Price · Currency is AUD
0.1000
+0.0020 (2.04%)
Aug 28, 2026, 10:15 AM AEST

Rhythm Biosciences Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Other Revenue
1.743.191.693.12.43
Revenue
1.743.191.693.12.43
Revenue Growth
-45.46%88.85%-45.41%27.54%118.98%
Cost of Revenue
0.410.223.05--
Gross Profit
1.332.97-1.363.12.43
Selling, General & Admin
5.955.1237.75.99
Research & Development
1.041.382.353.655.16
Amortization of Goodwill & Intangibles
---0.040.04
Operating Expenses
7.186.75.5511.5411.25
Operating Income
-5.86-3.73-6.91-8.44-8.82
Interest Expense
-0.07-0.07-0-0.01-
Interest & Investment Income
-0.130.050.230.02
EBT Excluding Unusual Items
-5.93-3.66-6.86-8.22-8.79
Merger & Restructuring Charges
--0.17---
Pretax Income
-5.93-3.83-6.86-8.22-8.79
Net Income
-5.93-3.83-6.86-8.22-8.79
Net Income to Common
-5.93-3.83-6.86-8.22-8.79
Net Income Growth
-----
Shares Outstanding (Basic)
335269228217210
Shares Outstanding (Diluted)
335269228217210
Shares Change
24.43%17.94%5.26%3.31%13.35%
EPS (Basic)
-0.02-0.01-0.03-0.04-0.04
EPS (Diluted)
-0.02-0.01-0.03-0.04-0.04
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-5.26-2.94-6.22-7.06-6.52
Free Cash Flow Per Share
-0.02-0.01-0.03-0.03-0.03
Gross Margin
76.29%92.95%-80.31%100.00%100.00%
Operating Margin
-336.37%-116.85%-408.60%-272.60%-363.29%
Profit Margin
-340.67%-119.97%-405.69%-265.44%-362.26%
Free Cash Flow Margin
-302.10%-92.25%-367.98%-227.94%-268.74%
EBITDA
-5.67-3.53-6.71-8.34-8.72
EBITDA Margin
--110.68%--269.35%-
D&A For EBITDA
0.190.20.20.10.09
EBIT
-5.86-3.73-6.91-8.44-8.82
EBIT Margin
--116.85%--272.60%-